Cargando…
The neoepitope landscape of breast cancer: implications for immunotherapy
BACKGROUND: Cancer immunotherapy with immune checkpoint blockade (CKB) is now standard of care for multiple cancers. The clinical response to CKB is associated with T cell immunity targeting cancer-induced mutations that generate novel HLA-binding epitopes (neoepitopes). METHODS: Here, we developed...
Autores principales: | Narang, Pooja, Chen, Meixuan, Sharma, Amit A., Anderson, Karen S., Wilson, Melissa A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6399957/ https://www.ncbi.nlm.nih.gov/pubmed/30832597 http://dx.doi.org/10.1186/s12885-019-5402-1 |
Ejemplares similares
-
The neoepitope landscape in pediatric cancers
por: Chang, Ti-Cheng, et al.
Publicado: (2017) -
Clinical implications of neoepitope landscapes for adult and pediatric cancers
por: Feng, Yang-Yang, et al.
Publicado: (2017) -
The Potential and Challenges of Exploiting the Vast But Dynamic Neoepitope Landscape for Immunotherapy
por: Verdegaal, Els M. E., et al.
Publicado: (2017) -
Unique genomic and neoepitope landscapes across tumors: a study across time, tissues, and space within a single lynch syndrome patient
por: Phung, Tanya N., et al.
Publicado: (2020) -
Boosting Antitumor Immunity with an Expanded Neoepitope Landscape
por: Nagel, Remco, et al.
Publicado: (2022)